YXYi Han Xia

Yi Han Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yi Han Xia has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immunophenotypic, Genetic, and Clinical Features Associated With RUNX1 Mutation in Acute Leukemias and Chronic Myeloid Neoplasms

    by Yi Han Xia, Eric McGinnis

    Introduction: RUNX1 is a commonly mutated transcriptional regulator of hematopoiesis in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Mutated RUNX1 (m RUNX1 ) may associate with cross‐lineage immunophenotypic aberrancy, presenting potential complications for blast lineage assignment at diagnosis. Methods: Clinical and laboratory data were reviewed for patients with RUNX1 mutations ( N = 125) at Vancouver General Hospital from 2016 to 2022. Diagnostic flow cytometry data were reanalyzed, and RUNX1 mutation characteristics and associations with pathologic, comutation, and flow cytometric features were assessed. Results: Missense RUNX1 mutations (overall 42.9% missense, 57.1% truncating) were enriched in the runt homology domain (RHD; 81.7%, Adj. p = 0.011). Several recurrent hotspot mutations were seen, including common hotspot variants. The most commonly comutated genes with RUNX1 in both acute leukemia with m RUNX1 and MDS‐m RUNX1 were ASXL1 (44.4%; 59.3%), SRSF2 (40.7%; 37.3%), and TET2 (35.8%; 55.9%). The m RUNX1 group demonstrated frequent positivity for B‐lymphoid markers, with 14.4% having increased expression in at least three B‐lineage markers. Differences in antigen expression were associated with RUNX1 mutation type and location, with increased CD10 expression associated with RUNX1 mutations in the RHD (Adj. p = 0.02764), and increased CD79a expression associated with RUNX1 missense mutations (Adj. p = 0.004452). Conclusion: In our cohort, we observed missense variants clustering in the RHD and recurrence of common pathogenic variants. Higher‐risk comutations were found in a substantial fraction of m RUNX1 cases which may contribute to its adverse risk associations. Comparable degrees of aberrancy in B‐lineage markers were seen in m RUNX1 patients versus the comparator cohorts of MPAL‐wt RUNX1 and AML with rearranged RUNX1 .

  • Open Access

    Neuronal lipid droplets play a conserved and sex-biased role in maintaining whole-body energy homeostasis

    by Romane Manceau, Celena M. Cherian, Danie Majeur, Colin J. Miller, Jasper D. Fisher, Frédérick Boisjoly, J. Beatrice Liston, Jennifer A. Bako, Lianna W. Wat, Charlotte F. Chao, et al.

    Lipids are essential for neuron development and physiology1,2,3. Yet, the central hubs that coordinate lipid supply and demand in neurons remain unclear4. Here we show the presence and functional significance of neuronal lipid droplets (nLDs) in vivo using invertebrate and vertebrate models. We validate5 the presence of nLDs in vivo and demonstrate that triglyceride metabolism enzymes and LD-associated proteins control nLD formation through both canonical and recently discovered pathways6. Modulation of nLDs has conserved and male-biased effects on whole-body energy homeostasis across flies and mice, specifically in neurons that couple environmental cues with energy homeostasis. Mechanistically, nLD-derived lipids support neuron function by providing fatty acids and phospholipids to sustain mitochondrial and endoplasmic reticulum function and homeostasis. This identifies a conserved role for nLDs in coordinating lipid supply and demand in neurons, which has implications for maintenance of neuronal lipid homeostasis and function in health and disease.


  • Open Access

    Prognostication of non–small cell lung cancer with concurrent chemoradiation treatment using neutrophil-to-lymphocyte ratio

    by Yi Han Xia, Luo Ting (Helen) Huang, Jee Suk Chang, Sanjay Rao, Amir Shafiee, Siavash Atrchian

    Purpose: We evaluated neutrophil-to-lymphocyte ratio (NLR) as a prognostic factor in patients with stage III unresectable non–small cell lung cancer (NSCLC) treated with concurrent chemoradiation (CRT). Furthermore, we examined neutrophil and lymphocyte changes to determine their contributions to NLR variation over time. Materials and Methods: A retrospective review was performed that included 262 patients diagnosed with stage III unresectable NSCLC from 2005 to 2020 who received concurrent CRT with a 60 Gy or 66 Gy in 30 fractions radiotherapy regimen. Pre-CRT NLR, lymphocyte nadir NLR, post-CRT NLR at 1 month ± 2-week intervals up to 6 months relative to the end of CRT, and NLR fold-change were calculated. The primary endpoint was overall survival.Results: Of the examined parameters, high NLR had the most consistently high prognostic value for poorer outcomes for all 3 endpoints in the 6-month period post-CRT, with the highest hazard ratios (HRs) at 3 to 4 months. This was associated with a decrease in neutrophils from 3 to 4 months, while NLR and lymphocytes were relatively stable. Several other parameters at 4 months, including individual cell counts and NLR fold-change (relative to the lymphocyte nadir), were associated with high HRs for mortality. Conclusion: Our study suggests that a window of time at 3 to 4 months post-CRT exists for when NLR and related hematologic parameters demonstrate increased prognostic value. This period may represent an area for further investigation as a potential opportunity for risk stratification with possible implications for surveillance and treatment.

  • Open Access

    Sex differences in islet stress responses support female beta cell resilience

    by George P. Brownrigg, Yi Han Xia, Chieh Min Jamie Chu, Su Wang, Charlotte Chao, Jiashuo Aaron Zhang, Søs Skovsø, Evgeniy Panzhinskiy, Xiaoke Hu, James D. Johnson, et al.

    Objective: Pancreatic β cells play a key role in glucose homeostasis; dysfunction of this critical cell type causes type 2 diabetes (T2D). Emerging evidence points to sex differences in β cells, but few studies have examined male-female differences in β cell stress responses and resilience across multiple contexts, including diabetes. Here, we address the need for high-quality information on sex differences in β cell/islet gene expression and function using both human and rodent samples. Methods: We compared β cell gene expression and insulin secretion in donors living with T2D to non-diabetic donors in both males and females. In mice, we generated a well-powered islet RNAseq dataset from 20-week-old male and female siblings with equivalent insulin sensitivity. Because on our unbiased analysis of gene expression pointed to sex differences in endoplasmic reticulum (ER) stress response, we subjected islets isolated from age-matched male and female mice to thapsigargin treatment and monitored protein synthesis, cell death, and β cell insulin production and secretion. Transcriptomic and proteomic analyses were used to characterize sex differences in islet responses to ER stress. Results: Our single-cell analysis of human β cells revealed sex-specific changes to gene expression and function in T2D, correlating with more robust insulin secretion in islets isolated from female donors living with T2D compared to male T2D donors. In mice, RNA sequencing revealed differential enrichment of unfolded protein response pathway-associated genes, where female islets showed higher expression of genes linked with protein synthesis, folding, and processing. This differential expression was biologically significant, as female islets were more resilient to ER stress induction with thapsigargin. Specifically, female islets maintained better insulin secretion and showed a distinct transcriptional response under ER stress compared with males. Conclusions: Our data demonstrate that physiologically significant sex differences in β cell gene expression exist in both humans and mice, and that female β cells maintain better insulin production and secretion across multiple physiological and pathological contexts.